The Drug Enforcement Administration has developed a comprehensive questionnaire for cannabis businesses seeking federal protections aligned with the ongoing rescheduling process. Obtained via public records requests, the 26-question document targets fundamental operational details. Regulators are specifically inquiring whether state-licensed operators intend to procure cannabis products across state lines, the exact product categories they manufacture or sell, and their primary supply chain partners.
This inquiry signals that federal oversight will remain stringent even as administrative shifts occur. Dispensary operators and brand managers must evaluate their documentation readiness. Interstate commerce remains restricted under current federal frameworks, making supply chain transparency essential.
The questionnaire suggests that federal agencies are actively mapping the commercial footprint of the state-legal cannabis industry—potentially laying groundwork for future regulatory enforcement or compliance standards. Stakeholders across the supply chain should review their inventory sourcing and vendor agreements to ensure complete traceability. Understanding these federal inquiries helps compliance officers anticipate federal expectations before rescheduling is finalized.